case-neonatal lupus

case-neonatal lupus

بیمار شیرخوار 6 ماهه ای است که از دو ماهگی دچارپاپول و پلاکهای اریتماتو مختصر پوسته دار روی صورت به خصوص پیشانی و اطراف چشمها شده که به تدریج گردن،تنه و اندامها را گرفتار کرده است.حال عمومی وی خوب بوده و مشکلی در بدو تولد نداشته است.

case-neonatal lupus1

case-neonatal lupus2

case-neonatal lupus3

DX or DDX?

مادر بیمار سابقه درد مفاصل دست را از حدود سه سال قبل ذکر می کرد ولی تشخیص خاصی داده نشده بود.در نهایت با بررسی های آزمایشگاهی و بیوپسی پوست تشخیص بیماری شیرخوار داده شد.بیماری مادر وی نیز تشخیص داده شد.

Erythematous, annular lesions with well-defined margins and lighter-colored centers on the face and periocular regions

case-neonatal lupus4

Erythematous, squamous, slightly atrophic lesions on the face, with polycyclic margins

case-neonatal lupus5

Annular lesions with erythematous, raised margins, with a lighter-colored center, located in the preauricular region

case-neonatal lupus6

Annular, erythematous, slightly atrophic plaques with telangiectasia on the scalp, in the temporal-occipital region and neck

case-neonatal lupus7

Neonatal lupus erythematosus

Neonatal lupus erythematosus (NLE) is characterized by the presence of skin lesions, abnormal cardiac function or both in newborn infants of mothers with auto-antibodies against Ro, La and/or, less commonly, U1RNP

It is a rare disease that affects approximately 1 in every 20,000 live-born infants, principally girls (65%)

It presents in the children of women who have been diagnosed with systemic lupus erythematosus (SLE), Sjogren’s syndrome and other types of collagen-vascular diseases

Approximately 50% of mothers are asymptomatic at the time of diagnosis, testing positive only against Ro auto-antibodies

It presents in the children of women who have been diagnosed with systemic lupus erythematosus (SLE), Sjogren’s syndrome and other types of collagen-vascular diseases

Approximately 50% of mothers are asymptomatic at the time of diagnosis, testing positive only against Ro auto-antibodies

The pathogenesis of this disorder remains to be fully clarified; however, the transplacental passage of antibodies, principally anti-Ro antibodies (present in 95% of cases of children with NLE and their mothers) is fundamental

The transitory nature of the manifestations that coincides with the disappearance of the antibodies circulating in the infant’s blood tends to confirm this hypothesis

The Ro antigen is found in the skin, heart, liver, bowel, lungs, brain and blood cells, the tissues that are most often affected by NLE.

Ultraviolet light and estrogens increase Ro antigen expression on the surface of the keratinocyte

Nevertheless, the presence of autoantibodies is necessary but insufficient in itself to produce NLE.

There is even discordance between twins; therefore, it is believed that unknown factors exist that render some infants susceptible in the presence of maternal autoantibodies

The skin lesions provoked by NLE may be congenital (20%) or appear during the first three months of life. They consist of erythematous, squamous plaques with raised margins and lighter colored centers.

They are annular or polycyclic in shape and disappear before the infant completes one year of life.

In the majority of patients, the lesions appear in photoexposed areas of the body (the face and scalp), although the skin of any other region may also be affected

Periocular erythema, referred to as “raccoon eyes” is a very common characteristic. Purplish, atrophic telangiectasias and erythema multiform-like lesions are less common

Treatment of the skin lesions consists of photoprotection and low-strength topical corticosteroids. Laser treatment may be necessary for residual telangiectasias.

The cardiologic abnormality that is characteristic of NLE is third-degree atrioventricular block, which develops in the second trimester of pregnancy and is permanent

Fetal brachycardia raises the suspicion of NLE during pregnancy and may be confirmed by fetal echocardiography.

The mortality rate in infants with congenital heart block (CHB) is around 20% even with implantation of a pacemaker, a procedure that is required in 50-100% of cases.

The risk of heart involvement in the firstborn child of an anti-Ro-positive mother is 1-2% and occurrence of the same disorder in a second child is 18%.

The efficacy of intravenous immunoglobulin is currently being evaluated for the prophylactic treatment of CHB in high-risk pregnancies (mothers who already have children with NLE) and it is recommended that fetal echocardiography should be performed from the sixteenth week of pregnancy onwards in all anti-Ropositive mothers

Liver involvement in NLE, which occurs in 10% of cases, usually manifests as liver failure, cholestasis or an increase in transaminase levels, which resolved spontaneously.

The most commonly described hematological manifestations (10% of cases) are thrombocytopenia, anemia, neutropenia and pancytopenia. These alterations are usually transitory and mild

Other organs such as the lungs and digestive tract are rarely affected.

The possibility of neurological involvement associated with NLE has been investigated.

Studies were conducted in which patients with NLE or the children of anti-Ro-positive mothers, were evaluated by neuroimaging and cephalic perimeter measurement. A greater frequency of abnormalities was found in these patients compared to healthy controls.

Differential diagnoses of skin lesions are made with seborrheic dermatitis, tinea corporis, psoriasis, atopic dermatitis, granuloma annulare, neonatal acne, erythema multiforme, Langerhans cell histiocytosis and congenital infections

The diagnosis of NLE is established from characteristic clinical findings and the identification of the abovementioned antibodies in the mother and child.

Histopathology of the skin is compatible with subacute cutaneous lupus, although in general this is not necessary for confirmation of diagnosis

The prognosis of the disease is defined by the cardiac involvement, since most of the other manifestations are transitory and self-resolving.

Long-term follow-up is vital in these patients, since they are at an increased risk of developing autoimmune diseases in late childhood or adulthood.

 

خواندن 2561 دفعه
Image

دکتر محمد ایمانی

متخصص پوست ، مو و زیبایی


پزشک: دکتر ایمانی
پرسشگر: Elmertet
تاریخ: دوشنبه, 05 مهر 1395 09:39
وضعیت: پاسخ داده شده

پرسش:
با سلام و خسته نباشید... جناب دکتر از سن 18سالگی در گیر بیماری ویتیلیگو هستم و بالای 60درصد بدنم رو درگیر کرده ولی رنگ لکه ها خیلی سفید نیست که تابلو باشه ...اولین سوالم اینه که این لکه ها مگه رنگ های سفیده کم رنگ پر رنگ داره؟ چون الان رنگشون مثل رنگ پوسته خیلی سفیده فرد عادیه... و دومین سوالم...آیا حقیقت داره در بیمارستان رازی آمپول هایی وجود داره و تزریق میکنن و پوست سفید میشه؟ هزینه اش چقدره؟ممنون لطفا پاسخ بدید

آقاي ساسان سلام

اگر بيماري در حال پيشرفت باشد،نقاط جديد بدن كه تازه دارند رنگدانه از دست مي دهند ولي هنوز روند پيشرفت ادامه دارد،خيلي سفيد نيستند،در خصوص سوال دوم،چنين آمپول و درماني وجود ندارد،بهترين درمان براي شما نور درماني هست .

 

دوست عزیز و گرامی من

زمان بهترین و ارزشمندترین هدیه ای است كه می توان به كسی ارزانی داشت.هنگامی كه برای كسی وقت می گذاریم، قسمتی از زندگی خود را به او میدهیم كه باز پس گرفته نمی شود . باعث خوشحالی و افتخار من است كه برای عزیزی مثل شما وقت می گذارم و امیدوارم كه با راهنماییهای اساتید این رشته واظهار نظر شما عزیزان این سایت آموزشی پر بارتر گردد.

اطلاعات تماس